The regulation of mitogenesis and apoptosis in response to the persistent stimulation of alpha1-adrenoceptors: a possible role of 15-lipoxygenase

Br J Pharmacol. 1997 Dec;122(7):1516-22. doi: 10.1038/sj.bjp.0701529.

Abstract

1. Activation of alpha1-adrenoceptor stimulation regulates eicosanoid metabolism and growth in vascular smooth muscle cells (VSMCs). The purpose of this study was to investigate the functional implications of lipoxygenase pathway in alpha1-adrenoceptor-stimulated VSMCs growth through mutually exclusive biological functions, that is cell proliferation and cell death. 2. Phenylephrine (10 microM), a specific alpha1-adrenoceptor agonist, enhanced [3H]-thymidine incorporation by 300% above basal. Nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor, caused 36 and 50% decrease in phenylephrine (10 microM)-stimulated [3H]-thymidine incorporation at concentrations of 1 microM and 10 microM respectively. 3. Inversely, treatment of phenylephrine (10 microM)-stimulated VSMCs with NDGA induced DNA fragmentation in a dose-dependent fashion. The level of induction of DNA fragmentation by NDGA was 225, 319 and 406% above the phenylephrine (10 microM)-level at concentrations of 0.1 microM, 1 microM and 10 microM, respectively. This induction of DNA fragmentation was partially prevented by exogenous 15-hydroxyeicosatetraenoic acid (15-HETE). The inhibition of apoptosis was 53 and 63% at concentrations of 5 microM and 10 microM of 15HETE, respectively, as compared with phenylephrine (10 microM) in the presence of NDGA (10 microM). 4. Furthermore, we performed the time-course analysis of Bcl-2 protein expression in phenylephrine (10 microM)-stimulated VSMCs. The expression of Bcl-2 protein disappeared after a 2 h incubation in the presence of NDGA (10 microM), but remained stable after a 2 h incubation period in the absence of NDGA (10 microM). 5, These results suggest that the lipoxygenase pathway is involved in cell proliferation by preventing apoptosis through the level of Bcl-2 protein expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-1 Receptor Agonists
  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Apoptosis / drug effects*
  • Arachidonate 15-Lipoxygenase / drug effects*
  • Arachidonate 15-Lipoxygenase / metabolism
  • Cell Division / drug effects*
  • Enzyme Activation
  • Female
  • Genes, bcl-2 / drug effects
  • Lipoxygenase Inhibitors / pharmacology*
  • Male
  • Masoprocol / pharmacology*
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects*
  • Phenylephrine / pharmacology
  • Rabbits
  • Receptors, Adrenergic, alpha-1 / drug effects*

Substances

  • Adrenergic alpha-1 Receptor Agonists
  • Adrenergic alpha-Agonists
  • Lipoxygenase Inhibitors
  • Receptors, Adrenergic, alpha-1
  • Phenylephrine
  • Masoprocol
  • Arachidonate 15-Lipoxygenase